COMMUNIQUÉS West-GlobeNewswire

A New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use
19/04/2018
New York, NY, April 19, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an investment company with medical instrumentation and biotechnology operations, announces the publication of new research utilizing [...]
Keryx Biopharmaceuticals Announces Late-breaking Ferric Citrate Abstract Accepted for Presentation at the 55th ERA-EDTA Congress
19/04/2018
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that data [...]
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
19/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Paratek Pharmaceuticals, Inc. Prices $140 Million of Convertible Senior Subordinated Notes due 2024
19/04/2018
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Imagin Medical Closes Oversubscribed Private Placement
19/04/2018
VANCOUVER, British Columbia and BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Imagin Medical, Inc. (CSE:IME) (OTC PINK:IMEXF) (Frankfurt/Stuttgart Stock Exchanges:DPD2) (the “Company”) announces that, further to its press [...]
Onconova Presents Data on Dual Inhibitor of CDK4/6 + ARK5 at American Association for Cancer Research 2018 Annual Meeting
19/04/2018
Onconova receives productive pre-IND guidance from FDA regarding first-in-class compound ON 123300 Preclinical data reveals differential metabolism of ON 123300 in male versus female rodents, with implications for [...]
Agritek Holdings Inc. Announces Celebration of 4/20 Through Company's Brand "Hemp Pops" Sales Giveaway
19/04/2018
LOS ANGELES, CA, April 19, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Eyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial Results
19/04/2018
NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
Nurses Call Liberal Pharmacare Resolution an Historic Opportunity
19/04/2018
CFNU President, Linda Silas, and NSNU President, Janet Hazelton, will attend Liberal convention to promote pharmacare for all HALIFAX, Nova Scotia, April 19, 2018 (GLOBE NEWSWIRE) -- At this weekend’s national [...]
Selon les infirmières et les infirmiers, la résolution des libéraux relative au régime d’assurance-médicaments représente une opportunité historique
19/04/2018
Linda Silas, présidente de la FCSII, et Janet Hazelton, présidente du SIINÉ, seront présentes, en qualité d’observatrices, au Congrès libéral afin de promouvoir le régime d’assurance-médicaments pour tous HALIFAX, [...]
Hemostemix Announces US FDA Clinical Trial Approval
19/04/2018
NOT FOR DISSEMINATON TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 19, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM), a clinical [...]
Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board
19/04/2018
IRVINE, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) today announced that it has added Harry L. Leider, MD, MBA to its Strategic Advisor Board, which is chaired by Edward W. (Ned) Barnholt [...]
Sharps Compliance Announces Third Quarter Fiscal 2018 Conference Call and Webcast
19/04/2018
HOUSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED ) announced today that it will release its third quarter results for the period ended March 31, 2018, before the opening of the financial [...]
Metabolon to Provide Metabolomic Profiling for the U.S. Veterans Administration Million Veteran Program
19/04/2018
RESEARCH TRIANGLE PARK, N.C. and ATLANTA, Ga., April 19, 2018 (GLOBE NEWSWIRE) -- Metabolon, Inc. , the global leader in metabolomics, announced today that the U.S. Department of Veterans Affairs (VA) has been [...]
Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease
19/04/2018
BEDMINSTER, N.J., April 19, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications [...]
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK Antibody Positive Myasthenia Gravis
19/04/2018
Pivotal Study sites in U.S. and Italy CORAL GABLES, Fla., April 19, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and [...]
iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37
19/04/2018
Company to showcase advanced, multi-platform electronic brachytherapy (eBx) technology in booth 6800 NASHUA, N.H. and BARCELONA, Spain, April 19, 2018 (GLOBE NEWSWIRE) -- ESTRO Booth 6800 -- iCAD, Inc. (NASDAQ: ICAD ), [...]
AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology
19/04/2018
Includes Initial Data from SMA Type 1 Pivotal Trial (STR1VE) and 24-Month Follow-Up Data from Phase 1 Trial CHICAGO, April 19, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company [...]
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
19/04/2018
KB103 represents the first investigational HSV-1 based gene therapy for the severe skin disorder dystrophic epidermolysis bullosa to receive this designation KB103 previously received Orphan Drug Designation for DEB [...]

Pages